A carregar...
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
Although many branded and generic antidepressants are approved for the treatment of major depressive disorder (MDD) in Canada, efficacy and tolerability differ among patients, and new treatment options are needed. Symptom types (eg, fatigue, energy/motivation, cognition, and functioning), medication...
Na minha lista:
| Publicado no: | Neuropsychiatr Dis Treat |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5716309/ https://ncbi.nlm.nih.gov/pubmed/29238196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S150589 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|